BODIPY FL thalidomide
Based on 1 Customer Validation
BODIPY FL thalidomide is a high-affinity and selective human cereblon (CRBN)-targeting fluorescent probe with a Kd of 3.6 nM. BODIPY FL thalidomide enables use as a probe in time-resolved fluorescence resonance energy transfer (TR-FRET) binding assays for cereblon ligands. BODIPY FL thalidomide supports development of highly sensitive, selective, stable cereblon TR-FRET binding assays (Ex/Em = 502/510 nm).
For research use only. We do not sell to patients.
- Purity: 99.18%
- CAS No.: 2740620-18-0
- Formula: C37H43BF2N6O7
- Molecular Weight:732.58
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
Cereblon 3.6 nM (Kd) |
BODIPY FL thalidomide (0.122-500 nM; 30-300 min) binds to 6×His-tagged human cereblon protein with high affinity, exhibiting a stable Kd of 3.6 nM after 90-240 min of incubation[1].
BODIPY FL thalidomide (4 nM; 30-300 min) mediates a TR-FRET assay that detects time-dependent changes in cereblon binding activity caused by the spontaneous isomerization of (S)- and (R)-Thalidomide enantiomers when incubated with 6×His-tagged human cereblon protein[1].
BODIPY FL thalidomide (4 nM; 90 min) mediates a TR-FRET assay that selectively detects binding of cereblon ligands to 6×His-tagged human cereblon protein, with no response to non-cereblon ligands[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2740620-18-0
-
Appearance Solid
-
Molecular Weight 732.58
-
Formula C37H43BF2N6O7
-
Color Orange to red
-
SMILES
O=C(COC1=CC=CC(C(N2C3C(NC(CC3)=O)=O)=O)=C1C2=O)NCCCCCCCCNC(CCC4=CC=C5C=C6C(C)=CC(C)=[N]6[B+3]([F-])([N-]54)[F-])=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 100 mg/mL (136.50 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.3650 mL | 6.8252 mL | 13.6504 mL | 34.1260 mL |
| 5 mM | 0.2730 mL | 1.3650 mL | 2.7301 mL | 6.8252 mL | |
| 10 mM | 0.1365 mL | 0.6825 mL | 1.3650 mL | 3.4126 mL | |
| 15 mM | 0.0910 mL | 0.4550 mL | 0.9100 mL | 2.2751 mL | |
| 20 mM | 0.0683 mL | 0.3413 mL | 0.6825 mL | 1.7063 mL | |
| 25 mM | 0.0546 mL | 0.2730 mL | 0.5460 mL | 1.3650 mL | |
| 30 mM | 0.0455 mL | 0.2275 mL | 0.4550 mL | 1.1375 mL | |
| 40 mM | 0.0341 mL | 0.1706 mL | 0.3413 mL | 0.8531 mL | |
| 50 mM | 0.0273 mL | 0.1365 mL | 0.2730 mL | 0.6825 mL | |
| 60 mM | 0.0228 mL | 0.1138 mL | 0.2275 mL | 0.5688 mL | |
| 80 mM | 0.0171 mL | 0.0853 mL | 0.1706 mL | 0.4266 mL | |
| 100 mM | 0.0137 mL | 0.0683 mL | 0.1365 mL | 0.3413 mL |
BODIPY FL thalidomide Related Classifications
Cat. No.: HY-152231
Powered by Bioz
- BODIPY FL thalidomide
- 2740620-18-0
- Fluorescent Dye
- Ligands for E3 Ligase
- human cereblon
- (R)-thalidomide
- 6×His-tagged human cereblon protein
- non-cereblon ligands
- (S)-thalidomide
- DMSO
- TR-FRET binding assays
- time-resolved fluorescence resonance energy transfer (TR-FRET)
- cereblon ligands
- human cereblon (CRBN)
- Inhibitor
- inhibitor
- inhibit